Allakos eyes recovery, retailers flock to drugmaker

Allakos

23/12/2021 11:47

** Shares of drug developer  ALLK.O  up 17.5% at $10.07
premarket, after falling ~90% in previous session
    ** Stock is top trending stock on investor-focused social
media Stocktwits.com
    ** Message vols on Stocktwits for ALLK up 23,452%
    ** ALLK crashed in Wednesday's session after co said its
lead drug failed to meet main goals of two trials measuring
symptoms of patients with types of gastrointestinal diseases,
while meeting two separate goals of the studies  urn:newsml:reuters.com:*:nL4N2T72GW
    ** 2 of 12 brokerages rate stock "buy", 7 "hold" and 3
"sell"; their median PT is $50 - Refinitiv data
    ** Nearly 1.3 mln shares traded by 0630 ET - second biggest
mover in premarket trading
    ** Up to last close, stock had fallen ~94% this year

 (Reporting by Bansari Mayur Kamdar in Bengaluru)
 ((BansariMayur.Kamdar@thomsonreuters.com;))